Focus on gastroesophageal reflux disease in patients with cystic fibrosis

Annarita Bongiovanni1, Sara Manti2, Giuseppe Fabio Parisi1

  • 1Department of Clinical and Experimental Medicine, Pediatric Respiratory Unit, San Marco Hospital, University of Catania, Catania 95123, Italy.

Insights

Gastroesophageal reflux disease (GERD) is common in cystic fibrosis (CF) patients, often starting in childhood. This review covers GERD

Area of Science:

  • Gastroenterology and Pulmonology
  • Pediatric Health

Background:

  • Gastroesophageal reflux disease (GERD) is a frequent comorbidity in cystic fibrosis (CF).
  • GERD prevalence in CF patients is notably high, often manifesting in childhood.
  • Existing diagnostic and therapeutic guidelines for GERD are not specific to CF patients.

Purpose of the Study:

  • To review the pathophysiology linking CF and GERD.
  • To outline diagnostic and therapeutic strategies for GERD in CF.
  • To discuss complications and future management directions for GERD in CF.

Main Methods:

  • Literature review of studies on GERD in CF patients.
  • Analysis of pathogenetic mechanisms connecting CF and GERD.
  • Synthesis of current diagnostic and treatment approaches.

Main Results:

  • Multiple pathogenetic mechanisms contribute to the CF-GERD association.
  • Current GERD management in CF relies on non-CF-specific guidelines.
  • There is a need for tailored approaches to GERD in CF.

Conclusions:

  • Understanding the unique aspects of GERD in CF is crucial.
  • Development of CF-specific GERD guidelines is warranted.
  • Further research is needed to optimize GERD management in cystic fibrosis.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
318
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
877
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
466
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
575
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
507
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
408